Tablet-based Interactive Distraction Preoperative Anxiety in Children: A Randomized Controlled Trial
NCT ID: NCT03531359
Last Updated: 2018-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
112 participants
INTERVENTIONAL
2018-07-04
2020-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Virtual Reality to Tablet-based Distraction in Children
NCT04414501
The Study Evaluates the Effect of an Interactive Projector as a Distraction for Children During Anesthetic Induction. The Primary Objective is to Reduce Perioperative Anxiety, Measured With the Modified Yale Preoperative Anxiety Scale (mYPAS).
NCT07230743
Technology-Based Distractions During Minor Procedures
NCT03628989
Reduction of Perioperative Anxiety Using a Hand-held Video Game Device
NCT04950088
Effects of Virtual Reality on Pre-Operative Anxiety and Induction of Anesthesia in Children and Adolescents
NCT03239743
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For the management of preoperative anxiety there are pharmacological and non-pharmacological treatments. Within the first group there's the use of benzodiazepines of short half life like midazolam, however, the use of this medication is not exempt of risks such as paradox reactions, respiratory depression, among others. This is why the non pharmacological mesures have taken force and every day there is more evidence regarding its effectiveness.
There are no reports in Chile or latin america regarding the use of this tools, this is why the investigators designed this study to prove the effectiveness of audiovisual distraction measures in reducing preparatory anxiety compared to premeditation with midazolam.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
Midazolam group: They'll receive 0,5mg/kg oral or it's equivalent in rectal administration 30 minutes to one hour prior to transfer to the theater. This patients will not be able to have contact with audiovisual devices.
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TIBD Tablet-based video distraction
Children will receive of tablet-based interctive games in preoperatory room
TIBD
Table-based Interactive Distraction using video-games will be used to prove efficacy in preventing preoperative anxiety.
Midazolam
Children will be premedicated with usual treatmente (midazolam)
Midazolam
Administration of midazolam oral or rectal 30 minutes to one hour prior to transfer to the theater.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TIBD
Table-based Interactive Distraction using video-games will be used to prove efficacy in preventing preoperative anxiety.
Midazolam
Administration of midazolam oral or rectal 30 minutes to one hour prior to transfer to the theater.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Carlos Van Buren
OTHER
Universidad de Valparaiso
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nathalie Lopez
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nathalie López, MD
Role: STUDY_DIRECTOR
Universidad de Valparaíso Chile
Anamaria Correa, MD
Role: PRINCIPAL_INVESTIGATOR
Universidad de Valparaíso Chile
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Carlos Van Buren
Valparaíso, , Chile
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UV-1-2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.